FASEKINK
Overview
🔒 Verified provider
E
8
ACTIVE PATIENTS
3
NEEDS REVIEW
82%
AVG ADHERENCE
2
REFILLS DUE
1
MOOD FLAG
Needs review today · 3
Patient roster
| PATIENT | PROTEIN | LAST SHOT | ADHERENCE |
|---|---|---|---|
MR Maya R. Semaglutide · weekly | 84g | 2d ago | 98% |
JT Jasmine T. Tirzepatide · weekly | 41g | 9d ago | 61% |
DW Deja W. Semaglutide · weekly | 96g | 4d ago | 100% |
CB Camille B. Semaglutide · weekly | 58g | 3d ago | 89% |
RK Renee K. Semaglutide · weekly | 77g | 6d ago | 92% |
PS Priya S. Tirzepatide · weekly | 68g | 5d ago | 82% |
AM Alicia M. Semaglutide · weekly | 61g | 7d ago | 76% |
TM Tasha M. Tirzepatide · weekly | 52g | 12d ago | 58% |
Patient detail
JTNeeds review
Jasmine T.
Tirzepatide · weekly
⚑ Missed injection · protein trending low
41g
Protein today
47g
7-day avg
-2.6 lb/wk
Weight pace
61%
Adherence
9 days ago
Last injection
6 days
Streak
LIFE SIGNAL · PATIENT-REPORTED
Motivation −3 vs baseline · 6 days
💬 Message
Preview of the PepOS web dashboard with sample patients. PepOS surfaces patient-reported data and informational flags — it does not diagnose, and every clinical and dosing decision stays with the provider. ← Back to site